Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Pacific Biosciences of California Inc (NASDAQ: PACB) closed the day trading at $1.37 up 0.74% from the previous closing price of $1.36. In other words, the price has increased by $0.74 from its previous closing price. On the day, 3.99 million shares were traded. PACB stock price reached its highest trading level at $1.4 during the session, while it also had its lowest trading level at $1.34.
Ratios:
For a better understanding of PACB, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.14 and its Current Ratio is at 8.01. In the meantime, Its Debt-to-Equity ratio is 1.88 whereas as Long-Term Debt/Eq ratio is at 1.85.
Goldman Downgraded its Buy to Neutral on April 18, 2024, whereas the target price for the stock was revised from $7 to $2.50.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 19 ’24 when Eidel Jeff sold 26,760 shares for $1.59 per share. The transaction valued at 42,602 led to the insider holds 869,730 shares of the business.
Van Oene Mark sold 38,011 shares of PACB for $63,174 on Aug 16 ’24. The insider now owns 1,630,815 shares after completing the transaction at $1.66 per share. On Aug 19 ’24, another insider, JEFFREY EIDEL, who serves as the Officer of the company, bought 26,760 shares for $1.59 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PACB now has a Market Capitalization of 373364736 and an Enterprise Value of 788513664. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.98 while its Price-to-Book (P/B) ratio in mrq is 0.76. Its current Enterprise Value per Revenue stands at 4.175 whereas that against EBITDA is -2.946.
Stock Price History:
Over the past 52 weeks, PACB has reached a high of $11.95, while it has fallen to a 52-week low of $1.16. The 50-Day Moving Average of the stock is -13.97%, while the 200-Day Moving Average is calculated to be -67.60%.
Shares Statistics:
Over the past 3-months, PACB traded about 8.77M shares per day on average, while over the past 10 days, PACB traded about 5878530 shares per day. A total of 267.74M shares are outstanding, with a floating share count of 262.15M. Insiders hold about 3.81% of the company’s shares, while institutions hold 83.94% stake in the company. Shares short for PACB as of 1723680000 were 59958923 with a Short Ratio of 6.83, compared to 1721001600 on 61682809. Therefore, it implies a Short% of Shares Outstanding of 59958923 and a Short% of Float of 25.34.
